Refine Results
  1. "Lymphoma"
Formats
  1. Meeting Abstract (858)
  2. Journal Article (808)
  3. Book Section (62)
  4. Conference Paper (11)
  5. Book Whole (4)
Groups
  1. Center for Hematologic Malignancies (1743)
  2. Lymphoma (1743)
  3. Hematologic Oncology, Division of (1693)
  4. Population Sciences Research Program (549)
  5. Survivorship Research (339)
  6. Executive Committee, Center for Hematologic Malignancies (280)

More Groups

People
  1. Andrew Zelenetz (599)
  2. Steven Horwitz (407)
  3. Craig Moskowitz (256)
  4. Anas Younes (243)
  5. David Straus (242)
  6. Ariela Noy (224)

More People

Years
  1. 2020 (25)
  2. 2019 (159)
  3. 2018 (133)
  4. 2017 (161)
  5. 2016 (146)
  6. 2015 (155)

More Years

Publications
  1. Blood (529)
  2. Journal of Clinical Oncology (203)
  3. Hematological Oncology (67)
  4. Leukemia and Lymphoma (55)
  5. Annals of Oncology (53)
  6. British Journal of Haematology (51)

More Publications

Publishers
  1. American Society of Hematology (540)
  2. American Society of Clinical Oncology (216)
  3. Wiley Blackwell (113)
  4. Elsevier Inc. (98)
  5. Oxford University Press (70)
  6. Nature Publishing Group (68)

More Publishers

Results (1743)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma
    Journal Article

    Timmerman, J.; Herbaux, C.; Ribrag, V.; Zelenetz, A. D.; Houot, R.; Neelapu, S. S.; Logan, T.; Lossos, I. S.; Urba, W.; Salles, G.; more...
    American Journal of Hematology (2020)

    Fulltext@MSK | Save
  • Safety and efficacy results from Transcend NHL 001, a multicenter phase 1 study of lisocabtagene maraleucel (liso-cel) In relapsed/refractory (R/R) large B-cell lymphoma (LBCL)
    Meeting Abstract

    Abramson, J.; Palomba, M. L.; Gordon, L.; Lunning, M.; Wang, M.; Arnason, J.; Mehta, A.; Purev, E.; Maloney, D.; Andreadis, C.; more...
    Oncology Research and Treatment (2020)

    Fulltext@MSK | Save
  • Clonal hematopoiesis (CH) in angioimmunoblastic T-cell lymphoma (AITL) with divergent evolution to myeloid neoplasms (MNs)
    Meeting Abstract

    Lewis, N.; Petrova-Drus, K.; Epstein-Peterson, Z.; Huet, S.; Gao, Q.; Sigler, A.; Baik, J.; Kumar, A.; Horwitz, S.; Zhang, Y.; more...
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • Infectious complications in aggressive B cell non-Hodgkin lymphoma after CD-19 chimeric antigen receptor T cell therapy
    Meeting Abstract

    Wudhikarn, K.; Pennisi, M.; Garcia Recio, M.; Maloy, M. A.; Shah, G. L.; Scordo, M.; Dahi, P. B.; Sauter, C. S.; Batlevi, C. W.; Palomba, M. L.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Comparative analysis of immune reconstitution in HIV-positive recipients of allogeneic and autologous stem cell transplant on the BMT-CTN-0903/AMC-080 and BMT-CTN-0803/AMC-071 trials
    Meeting Abstract

    Shindiapina, P.; Pietrzak, M.; Seweryn, M.; McLaughlin, E.; Zhang, X.; Makowski, M.; Lyberger, J.; Chang, H.; Ahmed, E.; Pearson, R.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Burden and impact of toxicities on outcomes for aggressive B cell non-Hodgkin lymphoma patients after CD19-directed chimeric antigen receptor T cell: Real-world experience
    Meeting Abstract

    Wudhikarn, K.; Pennisi, M.; Garcia Recio, M.; Flynn, J.; Maloy, M. A.; Devlin, S. M.; Batlevi, C. W.; Shah, G. L.; Scordo, M.; Palomba, M. L.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Hematopoietic recovery following chimeric antigen receptor T cell (CAR T) therapy in hematological malignancies
    Meeting Abstract

    Jain, T.; Knezevic, A.; Pennisi, M.; Ruiz, J. D.; Devlin, S. M.; Halton, E.; Diamonte, C.; Scordo, M.; Sauter, C. S.; Mead, E.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Comparing car T cells toxicities grading systems: Application of ASTCT grading system and implications for management
    Meeting Abstract

    Pennisi, M.; Jain, T.; Mead, E.; Santomasso, B.; Silverberg, M. L.; Batlevi, Y.; Shouval, R.; Devlin, S. M.; Batlevi, C. W.; Brentjens, R.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Outpatient treatment with lisocabtagene maraleucel (liso-cel) in 3 ongoing clinical studies in relapsed/refractory (R/R) large B cell non-Hodgkin lymphoma (NHL), including second-line transplant noneligible (TNE) patients: Transcend NHL 001, outreach, and PILOT
    Meeting Abstract

    Bachier, C. R.; Palomba, M. L.; Abramson, J. S.; Andreadis, C.; Sehgal, A.; Godwin, J.; Hildebrandt, G. C.; Siddiqi, T.; Stevens, D.; Farazi, T.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: A prospective cohort study from the international T-cell Project
    Journal Article

    Fox, C. P.; Civallero, M.; Ko, Y. H.; Manni, M.; Skrypets, T.; Pileri, S.; Kim, S. J.; Cabrera, M. E.; Shustov, A. R.; Chiattone, C. S.; more...
    The Lancet Haematology (2020)

    Fulltext@MSK | Save